A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex, is ...

-- Phase 1 clinical trial will evaluate the safety, tolerability, and pharmacokinetics -- SBS-147 is a novel and potent oral analgesic with a differentiated safety profile being developed for acute ...

The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx (suzetrigine) ...

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

The therapy’s development from Phase I to Phase II is funded by a $15m NIH/NIDA HEAL grant.

Pain has the potential to affect various aspects of a person’s life, from disrupting one’s daily routine to negatively impacting emotional well-being. It’s also one of the most common reasons that ...

We live in a nation of needless pain, where tens of millions suffer daily despite the existence of effective treatments. Yet ...

Learn about medication underuse headache (MUH), why taking your acute migraine meds early is key, and expert strategies for ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. On Thursday, the Food and Drug Administration (FDA) granted approval to Vertex Pharmaceuticals' non-opioid painkiller ...

After surgery, you’ll likely experience acute pain around the procedure site. Various pain management techniques can help you cope as you heal from your surgery. Managing pain after a surgical ...

Add Yahoo as a preferred source to see more of our stories on Google. For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an ...

The Food and Drug Administration has approved a new pain medication that could take the place of opioids for those experiencing moderate to severe acute pain. The drug is Journavx, or the generic name ...